Company News from the 04/07/06 News Brief

Share this article:
Pfizer has entered into an agreement to acquire Rinat Neuroscience, a privately held biotechnology company that is developing therapeutic proteins for the treatment of diseases and disorders of the central nervous system. Financial terms of the deal were not disclosed. Rinat’s lead product has just started Phase II trials as a treatment for osteoarthritis pain.
Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.